ZACHARON PHARMACEUTICALS
Zacharon Pharmaceuticals is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans. Zacharon was incorporated in 2004 and has received initial funding through NIH grants and individual investors. Series A financing was more recently provided by Avalon Ventures, a long-standing San Diego-based venture capital firm with a focus on early stage life science companies. With this strong financial backing and innovative drug development platform in place, Zacharon is developing an entirely new class of human therapeutics addressing substantial unmet needs.
ZACHARON PHARMACEUTICALS
Industry:
Biotechnology Developer Platform Health Care Therapeutics
Founded:
2004-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.zacharon.com
Total Employee:
1+
Status:
Closed
Contact:
858-459-9750
Email Addresses:
[email protected]
Total Funding:
4.03 M USD
Technology used in webpage:
SSL By Default IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL Cloudflare CDN
Similar Organizations
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Siva Therapeutics
Siva Therapeutics is a biotechnology company developing nanotechnology approaches for treating cancer.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Investors List
Avalon Ventures
Avalon Ventures investment in Series A - Zacharon Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Zacharon Pharmaceuticals
Official Site Inspections
http://www.zacharon.com
- Host name: 104.21.66.49
- IP address: 104.21.66.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
